Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
127120.KQ
STRONG SELLJS Link, Inc. · Healthcare · South Korea · $779M · Avg Vol: $5M/d
COMPANY DESCRIPTION
JS Link, Inc., a genome-based biotechnology company, focuses on the research and development of genome analysis services in South Korea and internationally.
FINANCIAL SUMMARY (USD)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR |
|---|---|---|---|---|---|
| Revenue | 11.2M | 14.4M | 10.5M | 12.7M | 4.4% |
| EPS | -0.15 | -0.21 | -0.36 | -0.40 | — |
| Shares | 34.5M | 18.7M | 22.5M | 34.1M | -1.2% |
| Debt | 4.0M | 2.8M | 12.6M | 28.5M | 92.3% |
| Equity | 18.4M | 17.3M | 16.5M | 45.2M | 35.0% |
| Op CF | 0.6M | -3.3M | -4.5M | -6.2M | — |
| Inv CF | -1.8M | -2.4M | -12.3M | -22.0M | — |
| Fin CF | 4.4M | 3.0M | 15.5M | 51.6M | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 127120.KQ are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| 127120.KQ | JS Link, Inc.(you) | $779M | 14 | STRONG SELL |
| 005690.KS | Pharmicell Co., Ltd. | $598M | 14 | STRONG SELL |
| 476830.KQ | Rznomics | $846M | 8 | STRONG SELL |
| 397030.KQ | AprilBio Co.,Ltd. | $621M | 10 | STRONG SELL |
| 085660.KQ | Chabiotech Co.,Ltd. | $595M | 10 | STRONG SELL |
| 475830.KQ | Orum Therapeutics, Inc. | $865M | 4 | STRONG SELL |
| 048410.KQ | Hyundai Bioscience Co., Ltd. | $578M | 7 | STRONG SELL |
| 115180.KQ | Qurient Co., Ltd. | $614M | 2 | STRONG SELL |
| 475960.KQ | TOMOCUBE | $325M | 12 | STRONG SELL |
| 174900.KQ | AbClon Inc. | $477M | 4 | STRONG SELL |
Peer medians: ROE -1.1% · P/E 17.7x · Gross margin 43.6%